A major Swedish study of 247,420 individuals with attention-deficit/hyperactivity disorder (ADHD) has found that medication ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

DELAWARE, DE, UNITED STATES, July 4, 2025 /EINPresswire.com/ -- The global Attention Deficit Hyperactivity Disorder (ADHD) market is anticipated to reach USD 18.3 billion by 2025, as a result of ...

People with ADHD often struggle with executive function, which Didier describes as “your brain’s GPS” for navigating your day ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

Attention-deficit/hyperactivity disorder (ADHD) medications remain associated with a reduced risk for various real-world ...

Discover a study that explores how a personalised mHealth exercise program can effectively improve ADHD symptoms in children.

When combined, a subjective list of common childhood behaviors (fidgeting, losing things, distractibility, not following ...

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...

The Food and Drug Administration is revising the labeling of all extended-release stimulants used to treat attention-deficit hyperactivity disorder to include warnings about the risk of weight loss ...